SYNTHETISCHE PEPTIDAMIDE

Patent europeic · EP2064228 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2064228
Numer da la dumonda
EP07870877
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-11-2007
Publitgà
03-06-2009
Concedì
29-08-2012
La protecziun finescha il pli tard
11-11-2027
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07K 5/107 (2006.01)
C07K 7/02 (2006.01)
A61K 38/07 (2006.01)
A61K 38/08 (2006.01)
Prioritad
US 858109 P 10.11.2006
US 928550 P 10.05.2007
Dumonda PCT
PCT/US2007/023858 12.11.2007
Publicaziun PCT
WO2008/057608 15.05.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Difelikefalin

C02064228/01 · Medicament · Concedì · Protecziun dals 12-11-2027 fin ils 11-11-2032

Admissiun 68653 (Swissmedic, 16-08-2022)

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-12-2025

    Represchentant stritgà

    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern (allontanà)

    Published in Swissreg on 30.12.2025

  2. 30-12-2025

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 30.12.2025

  3. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  4. 24-06-2025

    Transferì

    Owner
    Cara Therapeutics, Inc., 400 Atlantic Street, Suite 500, Stamford, CT 06901, USA → Vifor Fresenius Medical Care Renal Pharma Ltd., Rechenstrasse 37, 9014 St. Gallen
    Representative
    Bovard AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 24.06.2025

  5. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  6. 18-04-2024

    Adressa midada

    Owner
    Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th floor, Stamford, CT 06902, USA → Cara Therapeutics, Inc., 400 Atlantic Street, Suite 500, Stamford, CT 06901, USA

    Published in Swissreg on 18.04.2024

  7. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  8. 06-12-2022

    Midada

    Published in Swissreg on 06.12.2022

2 endataziuns pli veglias
  1. 17-10-2022

    Adressa midada

    Owner
    Cara Therapeutics, Inc., 1 Parrott Drive, Shelton, CT 06484, USA → Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th floor, Stamford, CT 06902, USA

    Published in Swissreg on 17.10.2022

  2. 29-08-2012

    Concedì

    Published in Swissreg on 29.08.2012

Partidas

Possessur

Vifor Fresenius Medical Care Renal Pharma Ltd.

Rechenstrasse 37, 9014 St. Gallen

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

SCHTEINGART, Claudio D.

San Diego, CA 92122, US

MENZAGHI, Frederique

Rye, NY 10580, US

JIANG, Guangcheng

San Diego, CA 92130, US

ALEXANDER, Roberta Vezza

San Diego, CA 92130, US

SUEIRAS-DIAZ, Javier

La Jolla, CA 92037, US

SPENCER, Robert H.

New Hope, PA 18938, US

CHALMERS, Derek T.

Riverside, CT 06878, US

LUO, Zhiyong

New City, NY 10956, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.